#EG5

Giuseppe MichieliGMIK69@mstdn.science
2024-07-26

Reduced #Likelihood of #Hospitalization with #JN1 or #HV1 #SARS-CoV-2 #Variants Compared to #EG5 Variant, J Infect Dis.: academic.oup.com/jid/advance-a

JN.1 and HV.1 variants may be associated with a lower #risk of severe illness. The severity of #COVID19 may have attenuated as predominant circulating SARS-CoV-2 lineages shifted from EG.5 to HV.1 to JN.1.

Giuseppe MichieliGMIK69@mstdn.science
2024-01-15

#Macau, Serviços de Saúde apelam aos residentes para prestarem maior #atenção à #prevenção do vírus #influenza e da #COVID19 devido ao crescimento dos casos em Macau gcs.gov.mo/detail/pt/N24ALK8Q5 #EG5 #BA286 #JN1

Giuseppe MichieliGMIK69@mstdn.science
2023-12-22

#Italy is experiencing the Christmas #COVID19 wave, according latest Min. of Health data: +10% of cases compared last week, 60,000 confirmed, hospitalization rate stable, predominant variant #EG5, with #JN1 rising rapidly, ilfattoquotidiano.it/2023/12/2

Giuseppe MichieliGMIK69@mstdn.science
2023-12-04

Breakthrough #infection elicits hypermutated IGHV3-53/3-66 public #antibodies with broad and potent neutralizing #activity against #SARS-CoV-2 variants including the emerging #EG5 lineages journals.plos.org/plospathogen

Still COVIDing Canadastillcovidingcanada@mstdn.ca
2023-12-02

2 new COVID-19 variants now dominant in N.B.

CBC News
November 28, 2023
By Bobbi-Jean MacKinnon

“Two new COVID-19 variants quickly gaining traction across Canada are already dominant in New Brunswick.”

stillcoviding.ca/en/news/2-new

#COVID #COVID19 #CovidIsNotOver #EG5 #HK3 #HV1 #NewBrunswick #PoPNB #SARSCoV2 #variants

Giuseppe MichieliGMIK69@mstdn.science
2023-12-01

-- Hospitals acute beds occupancy rate 9.5%, increasing
-- Mortality rate rising especially among elderly
-- Most representative variants currently circulating are the #EG5 and the #BA286, now at 10% of characterized isolates.

2023-11-29

#Schweiz

"#Blutwäsche bei Long Covid: Kein Geld für Studie

Kann eine Reinigung des Blutes Long-Covid-Patienten helfen? Diese Frage hätte eine Studie beantworten sollen. Doch die Mittel dazu fehlen."

#OmicronVariant #EG5 #Corona #Coronavirus #COVID19 #LongCovid #PostCovid #MECFS #POTS

nzz.ch/wissenschaft/blutwaesch

2023-11-12

Ich glaube nicht, dass die #Erinnerungen für die nächste Pandemie das Problem sein werden, sondern die anhaltende #Bildungsverweigerung und #Verschwörungsmythen​gläubigkeit der erwachsenen #Bevölkerung.

"Verzerrte Erinnerungen an #Corona
Laut neuer Studien beeinflusst die Impf-Identifikation die Erinnerung"

#OmicronVariant #EG5 #Corona #Coronavirus #COVID19 #LongCovid #PostCovid #MECFS #POTS #ImpfenSchützt #CoronaVaccine #COVIDVaccination #Impfstoff #BoosterImpfung

nd-aktuell.de/artikel/1177689.

2023-11-08

Nützen die neusten #Covid Impfungen von #BioNTech und #Moderna #XBB15 überhaupt gegen die zurzeit vorherrschende Variante #EG5 ?

Giuseppe MichieliGMIK69@mstdn.science
2023-11-01

#Italy, #Omicron subvariant #BA286 reported at 1.3% of genetically characterized isolates, with #EG5 still prevalent, #DV7 is also under monitoring, ilsole24ore.com/art/covid-iss- #SARS_COV_2 #covid19 #lineages #VUMs

iokevinsiokevins
2023-10-12

Novavax COVID-19 vaccination booster shot appointment made for Monday 💉 💜

-19

2023-10-10

"„Würde keine Maske mehr tragen“: Virologe #Drosten erwartet keinen heißen Corona-Winter

Sars-CoV-2 hat einen großen Teil seines anfänglichen Schreckens verloren. Ausgerechnet die vielen #Infektionen der Vorjahre lassen auch #ChristianDrosten gelassen auf den kommenden Winter blicken."

#OmicronVariant #EG5 #Corona #Coronavirus #COVID19 #ImpfenRettetLeben #ImpfenSchützt #CoronaVaccine #COVIDVaccination #Impfstoff #BoosterImpfung

tagesspiegel.de/gesundheit/wur

Giuseppe MichieliGMIK69@mstdn.science
2023-10-06

''6 Oct. '23 Highlights: * during surveillance week, the incidence of new detected cases of #COVID19 remained low and overall stable. * #Impact on #healthcare system, especially #ICUs was limited. * Predominance of #omicron #XBB lineages was confirmed, especially with #EG5 subvariant, similarly other European regions.'' #surveillance #italy #SARS_COV_2

kurtshkurtsh
2023-09-25
Giuseppe MichieliGMIK69@mstdn.science
2023-09-14

''...results suggest that rise of #EG5 & #EG51, as well as #XBB23, infections might not be due to increased capacity ...to enter target cells; ... Of few therapeutic #antibodies still considered useful in clinic, #sotrovimab inhibited both EG.5.1pp & XBB.2.3pp, at least at high concentrations. Finally, we obtained evidence that EG.5.1 evades neutralising antibodies with increased efficiency, at least in context of the immune background of the plasma donors analysed.''

Client Info

Server: https://mastodon.social
Version: 2025.07
Repository: https://github.com/cyevgeniy/lmst